Lv1
38 积分 2025-04-03 加入
A patent review of NLRP3 inhibitors for inflammatory diseases (2023-present)
2个月前
已完结
Chemical Structural Alert and Reactive Metabolite Concept as Applied in Medicinal Chemistry to Minimize the Toxicity of Drug Candidates
2个月前
已完结
Cardiovascular, Kidney, Liver, and Metabolic Interactions in Heart Failure: Breaking Down Silos
3个月前
已完结
The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases
3个月前
已完结
The persisting puzzle of OFF time in advanced Parkinson’s disease
3个月前
已完结
Metabolic Dysfunction–Associated Steatotic Liver Disease in Adults
4个月前
已完结
Marine natural products
5个月前
已完结
HDAC6/Trim21 aggravates macrophage inflammatory response and titanium-induced osteolysis via GSDMD signaling pathway
5个月前
已完结
The global epidemiology of acute myeloid leukaemia
6个月前
已完结
The Selective NLRP3-Inflammasome Inhibitor CY-09 AmelioratesKidney Injury in Diabetic Nephropathy by Inhibiting NLRP3-inflammasome Activation
7个月前
已完结
皖公网安备34019202002308
